ChemicalBook > CAS DataBase List > antarelix

antarelix

Product Name
antarelix
CAS No.
151272-78-5
Chemical Name
antarelix
Synonyms
antarelix;D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-
CBNumber
CB31383659
Molecular Formula
C74H100ClN15O14
Formula Weight
1459.13
MOL File
151272-78-5.mol
More
Less

antarelix Property

Water Solubility 
>10g/L(temperature not stated)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation
Product number
PEP0003615
Product name
ANTARELIX
Purity
95.00%
Packaging
1MG
Price
$836.8
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
PEP0003615
Product name
ANTARELIX
Purity
95.00%
Packaging
5MG
Price
$1791.41
Updated
2021/12/16
More
Less

antarelix Chemical Properties,Usage,Production

Uses

Teverelix (EP 24332) is a GnRH antagonist. Teverelix binds competitively and reversibly to GnRH receptors, thereby suppressing the release of LH and FSH. Teverelix can be used in the research of prostatic hyperplasia, endometriosis, and prostate cancer[1][2].

in vivo

Teverelix (3-300 μg/kg, intramuscular injection) inhibits testosterone in rats[3].
Teverelix (1 mg/kg, s.c, daily for 3 days) abolishes luteal function in stumptailed macaques[4].

Animal Model:Rats[3]
Dosage:300, 100, 30, 10 and 3 μg/kg
Administration:Intramuscular injection
Result:Showed dose-response and time-course of testosterone inhibitory activity.

References

[1] MacLean CM, et al. Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin-Releasing Hormone Antagonist, in Healthy Adult Subjects. Clin Pharmacol Drug Dev. 2022 Feb;11(2):257-269. DOI:10.1002/cpdd.1008
[2] Sperduti S, et al. GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors. Int J Mol Sci. 2019 Nov 7;20(22):5548. DOI:10.3390/ijms20225548
[3] Deghenghi R, et al. Antarelix (EP 24332) a novel water soluble LHRH antagonist. Biomed Pharmacother. 1993;47(2-3):107-10. DOI:10.1016/0753-3322(93)90299-z
[4] Fraser HM, et al. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge. Hum Reprod. 1997 Mar;12(3):430-5. DOI:10.1093/humrep/12.3.430

antarelix Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

antarelix Suppliers

Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Email
Eric@peptidego.com
Country
China
ProdList
7408
Advantage
58
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
Tel
0571-87213919 17306812703
Email
3007955328@qq.com
Country
China
ProdList
6979
Advantage
58
TargetMol Chemicals Inc.
Tel
15002134094
Email
marketing@targetmol.cn
Country
China
ProdList
29257
Advantage
58
YantaiBio
Tel
13758194781 15083780366
Email
wudegui@tanzhenbio.com
Country
China
ProdList
1591
Advantage
58
Fuan Bio
Tel
18178976185
Email
3855357086@qq.com
Country
China
ProdList
2061
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
Guangzhou Suyan Biotechnology Co., Ltd
Tel
18818417021
Country
CHINA
ProdList
127
Advantage
58

151272-78-5, antarelixRelated Search:


  • antarelix
  • D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-
  • 151272-78-5
  • C74H100ClN15O14